- Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?
-
Yvan-Charvet L, Ivanov S
- KMID: 2501303
- J Lipid Atheroscler.
- 2020 May;9(2):231-242.
- doi: 10.12997/jla.2020.9.2.231
Hypercholesterolemia contributes to the chronic inflammatory response during the progression of atherosclerosis, in part by favoring cholesterol loading in macrophages and other immune cells. However, macrophages encounter a substantial amount... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardiovascular Risk Factors: It's Time to Focus on Variability!
-
Barnett MP, Bangalore
- KMID: 2501305
- J Lipid Atheroscler.
- 2020 May;9(2):255-267.
- doi: 10.12997/jla.2020.9.2.255
Atherosclerotic heart disease remains a leading cause of morbidity and mortality worldwide. While extensive research supports cardiovascular risk factor reduction in the form of achieving evidence-based blood pressure, lipid, glucose,... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion
-
Kim GT, Kim SJ, Park SH, Lee D, Park TS
- KMID: 2501308
- J Lipid Atheroscler.
- 2020 May;9(2):291-303.
- doi: 10.12997/jla.2020.9.2.291
Objective: Ceramide is a signaling molecule that contributes to insulin resistance and hepatosteatosis. In the present study, we activated de novo ceramide synthesis by inducing the hepatic expression of Sptlc2... -
- CITED
-
- Close
- SHARE
-
- Close
- Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin
-
Kim H, Lee CJ, Choi D, Kim BK, Kim IC, Kim JS, Ahn CM, Hong GR, Cho IJ, Shim CY, Lee SH
- KMID: 2501307
- J Lipid Atheroscler.
- 2020 May;9(2):283-290.
- doi: 10.12997/jla.2020.9.2.283
Objective: The aim of this study was to investigate whether a new generic rosuvastatin is non-inferior to a proprietary one in terms of lipid-lowering efficacy. We also evaluated its non-lipid... -
- CITED
-
- Close
- SHARE
-
- Close
- Toward the Clinical Application of Therapeutic Angiogenesis Against Pediatric Ischemic Retinopathy
-
Jo DH, Kim JH
- KMID: 2501306
- J Lipid Atheroscler.
- 2020 May;9(2):268-282.
- doi: 10.12997/jla.2020.9.2.268
Therapeutic angiogenesis refers to strategies of inducing angiogenesis to treat diseases involving ischemic conditions. Historically, most attempts and achievements have been related to coronary and peripheral artery diseases. In this... -
- CITED
-
- Close
- SHARE
-
- Close
- Regulatory Effects of O-GlcNAcylation in Vascular Smooth Muscle Cells on Diabetic Vasculopathy
-
Byon CH, Kim SW
- KMID: 2501304
- J Lipid Atheroscler.
- 2020 May;9(2):243-254.
- doi: 10.12997/jla.2020.9.2.243
Vascular complications from uncontrolled hyperglycemia are the leading cause of death in patients with diabetes mellitus. Previous reports have shown a strong correlation between hyperglycemia and vascular calcification, which increases... -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative Cessation of Both Dual Anti-Platelet Agents Is Safe after 1 Year in Patients Receiving Percutaneous Coronary Intervention
-
Lee JH, Jo SH
- KMID: 2501309
- J Lipid Atheroscler.
- 2020 May;9(2):304-312.
- doi: 10.12997/jla.2020.9.2.304
Objective: The aim of this study was to investigate the atherothrombotic and bleeding risk of discontinuing both components of dual antiplatelet therapy (DAPT) before surgery in patients with an intracoronary... -
- CITED
-
- Close
- SHARE
-
- Close
